Cramer's 'Mad Money' Recap: Stocks With Great Earnings Visibility

In addition, the company, which should enjoy tremendous growth over the next five years, is expected to announce its first utility customers in the U.S. in 2008, a catalyst that should boost the stock.

Medco Health Solutions

The second company with "bedrock earnings visibility" people can count on in this unpredictable environment is Medco Health Solutions (MHS Quote), another stock that's down in price right now, Cramer said.

This pharmacy benefit manager, he told viewers, benefits when big drug companies come off patent and go generic. Over the next five years, $77 billion worth of drug sales are scheduled to come off patent, Cramer explained.

Because Medco Health does an enormous amount of drug buying, generic versions will send its cost down significantly and increase its profit margins tremendously.

During the next five years, there is a $6 billion window of profit opportunity for the company, and the best part about it is that people can see this now, he said.

If this stock comes down from $98.42 to the low $90s, Cramer said he wouldn't be surprised if the company started buying stock back. "It has the kind of visibility investors should kill for," he said.

Moreover, Medco Health is a defensive stock and should be OK to buy in this erratic market, Cramer added. He said people should buy it slowly.